Monoclonal antibodies byjus

As countries continue to roll out vaccines to prevent COVID-19 and achieve herd immunity, scientists continue to work on developing treatments for the disease. The Monoclonal antibodies gained media attention with the This article provides an overview of the current state of monoclonal antibodies for COVID-19 treatment. Medical News Today also reached out to Article highlights: The body’s immune system generates Antibodies bind to antigens. This tells specialized cells of the immune system to kill the invading pathogen. The bodies of the majority of people who recover from COVID-19 produce antibodies to the SARS-CoV-2 virus. Scientists have found that these antibodies persist for at least However, scientists can also produce these antibodies in a laboratory setting to be infused into the blood. They can then select a single white blood cell or clone and use this as the basis to produce many identical cells, making many identical copies of the monoclonal antibody. Antibody treatments in themselves are not new. Healthcare professionals have used monoclonal antibodies, for example, to treat viral infections such as Each monoclonal antibody is specific to its matching antigen. For COVID-19, there are several authorized monoclonal antibody therapies. The SARS-CoV-2 virus’s spike glycoprotein, which sits on its surface, functions to facilitate the virus’s entry into the body’s cells. Some SARS-CoV-2 antibodies bind to the spike protein and prevent the virus from entering the cel...